APPLICATION
ANDA206736
TYPE
ANDA
ORIGINAL APPROVAL
2016-01-19
LATEST ACTION
2020-07-06
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
RIFAMPINDiscontinued
RIFAMPIN 600MG/VIAL · INJECTABLE · INJECTION
Approval history
2020-07-06Labeling · Supplement 1 · standardAP
2020-07-06Labeling · Supplement 2 · standardAP
2020-07-06Labeling · Supplement 3 · standardAP
2016-01-19UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.